{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:47:15Z","timestamp":1768258035086,"version":"3.49.0"},"reference-count":30,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j131","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:11:29Z","timestamp":1730913089000},"page":"353-360","source":"Crossref","is-referenced-by-count":1,"title":["Up-Regulated MiR-616-5p Promotes the Progression of Nasopharynx Cancer through GSK3<i>\u03b2<\/i>"],"prefix":"10.1620","volume":"266","author":[{"given":"Shasha","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Sanmen People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sanmen People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sanmen People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"He","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Jiangxi Medical College, Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juying","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sanmen People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"An, X., Jiang, Y., Chen, D. & Chen, J.(2021) Insulin receptor substrate-1 and dishevelled 2 are negatively regulated by microRNA-144 and inhibit nasopharyngeal carcinoma cell malignancy. Exp. Ther. Med<\/i>., 22, 1303.","DOI":"10.3892\/etm.2021.10738"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Arabkari, V., Sultana, A., Barua, D., Webber, M., Smith, T., Gupta, A. & Gupta, S.(2023) UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC. Int. J. Mol. Sci<\/i>., 24, 13034.","DOI":"10.3390\/ijms241713034"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh, M., Najafi, M., Ang, H.L., Moghadam, E.R., Mahabady, M.K., Zabolian, A., Jafaripour, L., Bejandi, A.K., Hushmandi, K., Saleki, H., Zarrabi, A. & Kumar, A.P.(2020) PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines<\/i>, 8, 264.","DOI":"10.3390\/biomedicines8080264"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bousquet, M., Harris, M.H., Zhou, B. & Lodish, H.F.(2010) MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. U. S. A.<\/i>, 107, 21558-21563.","DOI":"10.1073\/pnas.1016611107"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cai, B., Qu, X., Kan, D. & Luo, Y.(2022) miR-26a-5p suppresses nasopharyngeal carcinoma progression by inhibiting PTGS2 expression. Cell Cycle<\/i>, 21, 618-629.","DOI":"10.1080\/15384101.2022.2030168"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cao, C., Xu, Y., Huang, S., Jiang, F., Jin, T., Jin, Q., Hua, Y., Hu, Q. & Chen, X.(2021) Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET\/MR. Front. Oncol<\/i>., 11, 763114.","DOI":"10.3389\/fonc.2021.763114"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Chen, F., Shen, C., Wang, X., Wang, H., Liu, Y., Yu, C., Lv, J., He, J. & Wen, Z.(2017) Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis. Oncotarget<\/i>, 8, 63738-63749.","DOI":"10.18632\/oncotarget.19478"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chen, Z., Su, Y., Lin, D., Chen, M., Feng, S. & Zou, C.(2019) Metabolic characteristics revealing cell differentiation of nasopharyngeal carcinoma by combining NMR spectroscopy with Raman spectroscopy. Cancer Cell Int<\/i>., 19, 37.","DOI":"10.1186\/s12935-019-0759-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Cheng, C., Li, W., Peng, X., Liu, X., Zhang, Z., Liu, Z., Deng, T., Luo, R., Fang, W. & Deng, X.(2021) miR-1254 induced by NESG1 inactivates HDGF\/DDX5-stimulated nuclear translocation of beta-catenin and suppresses NPC metastasis. Mol. Ther. Methods Clin. Dev<\/i>., 20, 615-624.","DOI":"10.1016\/j.omtm.2021.02.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Du, Y., Wu, J. & Luo, L.(2018) Secreted Heat Shock Protein 90alpha Attenuated the Effect of Anticancer Drugs in Small-Cell Lung Cancer Cells Through AKT\/GSK3beta\/beta-Catenin Signaling. Cancer Control<\/i>, 25, 1073274818804489.","DOI":"10.1177\/1073274818804489"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Emdad, L., Janjic, A., Alzubi, M.A., Hu, B., Santhekadur, P.K., Menezes, M.E., Shen, X.N., Das, S.K., Sarkar, D. & Fisher, P.B.(2015) Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness. Neuro Oncol<\/i>., 17, 419-429.","DOI":"10.1093\/neuonc\/nou220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fan, J.Y., Liu, J., Zhang, W.Q., Lin, T., Hu, X.R., Zhou, F.L., Tang, L., He, Y.C. & Shi, H.J.(2023) Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking. Medicine (Baltimore)<\/i>, 102, e36477.","DOI":"10.1097\/MD.0000000000036477"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hu, W., Xiao, L., Cao, C., Hua, S. & Wu, D.(2016) UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT\/GSK3beta\/beta-catenin pathway. Oncotarget<\/i>, 7, 15161-15172.","DOI":"10.18632\/oncotarget.7805"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Jiang, N., Zhao, L., Zong, D., Yin, L., Wu, L., Chen, C., Song, X., Zhang, Q., Jiang, X., He, X. & Feng, J.(2021) Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p. Bioengineered<\/i>, 12, 10716-10728.","DOI":"10.1080\/21655979.2021.2001952"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lauretti, E., Dincer, O. & Pratico, D.(2020) Glycogen synthase kinase-3 signaling in Alzheimer's disease. Biochim. Biophys. Acta. Mol. Cell. Res<\/i>., 1867, 118664.","DOI":"10.1016\/j.bbamcr.2020.118664"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Li, H.L., Deng, N.H., He, X.S. & Li, Y.H.(2022) Small biomarkers with massive impacts: PI3K\/AKT\/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma. Biomark. Res<\/i>., 10, 52.","DOI":"10.1186\/s40364-022-00397-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Liu, F. & Li, S.(2022) Non-coding RNAs in skin cancers: Biological roles and molecular mechanisms. Front. Pharmacol<\/i>., 13, 934396.","DOI":"10.3389\/fphar.2022.934396"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Liu, X.F., Li, X.Y., Zheng, P.S. & Yang, W.T.(2018) DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt\/beta-catenin pathway via GSK3beta. Cell Death Dis<\/i>., 9, 339.","DOI":"10.1038\/s41419-018-0359-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Merkel, C. & Morabito, A.(1994) Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding: a meta-analysis assessment. J. Hepatol<\/i>., 21, 918-919.","DOI":"10.1016\/S0168-8278(94)80265-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Pan, S., Liang, S. & Wang, X.(2021) ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K\/AKT\/GSK-3beta\/beta-catenin signaling. Life Sci<\/i>., 278, 119581.","DOI":"10.1016\/j.lfs.2021.119581"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ren, W., Hu, J., Li, H., Chen, J., Ding, J., Zu, X. & Fan, B.(2021) miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression. Front. Oncol<\/i>., 11, 762946.","DOI":"10.3389\/fonc.2021.762946"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wang, D.X., Zou, Y.J., Zhuang, X.B., Chen, S.X., Lin, Y., Li, W.L., Lin, J.J. & Lin, Z.Q.(2017) Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3beta\/beta-catenin signaling pathways. Acta. Pharmacol. Sin<\/i>., 38, 241-251.","DOI":"10.1038\/aps.2016.122"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wu, X., Cai, D., Zhang, F., Li, M. & Wan, Q.(2019) Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma. Life Sci<\/i>., 231, 116549.","DOI":"10.1016\/j.lfs.2019.116549"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Yin, W., Wang, J., Jiang, L. & James Kang, Y.(2021) Cancer and stem cells. Exp. Biol. Med. (Maywood)<\/i>, 246, 1791-1801.","DOI":"10.1177\/15353702211005390"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yuan, C.(2019) miR-616 promotes breast cancer migration and invasion by targeting TIMP2 and regulating MMP signaling. Oncol. Lett<\/i>., 18, 2348-2355.","DOI":"10.3892\/ol.2019.10546"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Zhang, D., Zhou, P., Wang, W., Wang, X., Li, J., Sun, X. & Zhang, L.(2016) MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol. Rep<\/i>., 35, 366-374.","DOI":"10.3892\/or.2015.4334"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhang, F., Yin, Y., Xu, W., Zhou, Z., Sun, X. & Li, P.(2021) Apatinib combined with Keytruda treatment induces apoptosis of gastric carcinoma cells through CES4\/miR-616-5p\/DUSP2 axis. Basic Clin. Pharmacol. Toxicol<\/i>., 129, 345-356.","DOI":"10.1111\/bcpt.13641"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhang, P., Tian, Q., Gao, H., Zhao, A., Shao, Y. & Yang, J.(2022) Inhibition of MAC30 exerts antitumor effects in nasopharyngeal carcinoma via affecting the Akt\/GSK-3beta\/beta-catenin pathway. J. Biochem. Mol. Toxicol<\/i>., 36, e23061.","DOI":"10.1002\/jbt.23061"},{"key":"29","unstructured":"Zhu, L.M. & Li, N.(2020) Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p\/GSK3beta pathway in ovarian cancer. Eur. Rev. Med. Pharmacol. Sci<\/i>., 24, 7253-7265."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhuang, M., Zhang, T., Chen, Z., Lin, Z., Li, D., Peng, X., Qiu, Q. & Wu, R.(2013) Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams. Radiat. Oncol<\/i>., 8, 120.","DOI":"10.1186\/1748-717X-8-120"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2024.J131\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:41:56Z","timestamp":1755920516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/4\/266_2024.J131\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j131","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J131"}}